Please login to the form below

Not currently logged in
Email:
Password:

Jane Griffiths

This page shows the latest Jane Griffiths news and features for those working in and with pharma, biotech and healthcare.

Pharma needs to 'better articulate' its value to society

Pharma needs to 'better articulate' its value to society

Incentivising innovation. Also speaking at the event in Barcelona was Janssen's company group chairman Jane Griffiths who noted that there has to be profit element to the pharma business model ... Looking to more recent measures and Griffiths pointed to

Latest news

More from news
Approximately 1 fully matching, plus 11 partially matching documents found.

Latest Intelligence

  • Interview: Jane Griffiths, Janssen EMEA Interview: Jane Griffiths, Janssen EMEA

    Jane Griffiths on Janssens' 'diversity of thought' and taking a hands on approach to CSR. ... Biography. Jane Griffiths completed a PhD in Biochemistry at the University of Aberystwyth in the UK in 1982.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • J&J's Jane Griffiths named global head of Actelion J&J's Jane Griffiths named global head of Actelion

    J&J's Jane Griffiths named global head of Actelion. Appointment will effect once Swiss biotech's acquisition is completed. ... Johnson &Johnson has picked Jane Griffiths to serve as global head of Actelion, the Swiss biotech it is in the process of

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

We are industry-leading thinkers when it comes to education. We use the latest academic thinking on the psychology of behaviour...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics